Broward Health intends to use the bonds to fund capital investments, including expanding its Fort Lauderdale-based Salah Foundation Children’s Hospital at Broward Health. A portion of the bonds will refinance variable debt with long-term fixed rate borrowing and boost Broward Health’s unrestricted cash balances.
“Achieving an appropriate level of permanence to the capital structure of Broward Health is vital to its financial stability and ability to fulfill its mission,” said Christopher Ure, North Broward Hospital District Board vice chair.
Broward Health interim CEO Beverly Capasso added the bond sale marks “a significant milestone in our turnaround and transformation.”
More articles on healthcare finance:
CHS in negotiations to extend nearly $2B in debt
OIG: Rush University Medical Center overbilled Medicare by $10.2M
Allina Health reports 6-fold rise in net income
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
